Re:Mylan’s EpiPen price hike was a scheme to stifle competit...
by 086421357909764 on Wednesday April 26, 2017 @11:41AM
(#14203948)
I think the argument here is that they were forced to sell the competing product to a new vendor (due to stifled competition) whom are now pricing at $4500, which they weren't.
[ Parent
| on HN ]
There are no comments on this comment yet.